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Abstract
Background: Histamine-related drugs are commonly used in the treatment of vertigo and related
vestibular disorders. The site of action of these drugs however has not been elucidated yet. Recent
works on amphibians showed that histamine H3 receptor antagonists, e.g. betahistine, inhibit the
afferent discharge recorded from the vestibular nerve. To assess the expression of H3 histamine
receptors in vestibular neurons, we performed mRNA RT-PCR and immunofluorescence
experiments in mouse Scarpa's ganglia.
Results: RT-PCR analysis showed the presence of H3 receptor mRNA in mouse ganglia tissue. H3
protein expression was found in vestibular neurons characterized by large and roundish soma,
which labeled for calretinin and calbindin.
Conclusion: The present results are consistent with calyx and dimorphic, but not bouton, afferent
vestibular neurons expressing H3 receptors. This study provides a molecular substrate for the
effects of histamine-related antivertigo drugs acting on (or binding to) H3 receptors, and suggest a
potential target for the treatment of vestibular disorders of peripheral origin.
Background
The vestibular, or balance, organs inform the brain about
the movements and position of the head. The sensory
receptors of the vestibular apparatus are the hair cells. Two
types of hair cells are present in mammalian vestibular
organs, called Type I and Type II hair cells, which differ
substantially in their afferent contact. The Type I hair cell's
basolateral membrane is completely enveloped in a large
afferent nervous terminal, called a calyx. In contrast, Type
II hair cells are contacted by numerous bouton-like affer-
ent terminals. The soma of afferent neurons are located in
the Scarpa's ganglion. Central projections of the vestibular
nerve contact secondary neurons located in the brainstem
(vestibular nuclei) and in the cerebellum, which provide
the anatomical basis for the vestibular reflexes.
Most cases of dizziness and vertigo are due to problems in
vestibular organs, presumably resulting in wrong afferent
signaling interpreted by the brain as if the head is moving
or turning when it is actually not.
Among the pharmacological compounds commonly used
in the symptomatic treatment of vertigo and related ves-
tibular disorders are histamine-related drugs, such as pro-
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methazine [1], dimenhydrinate [2] and cinnarizine [3],
assumed to act at H1 histamine receptors, and betahistine
[4,5], which has been shown to act as an H3 histamine
receptor antagonist [6]. However, the site/s of action of
these drugs have not been defined. Histamine H1, H2 and
H3 receptor subtype expression has been reported in rat
vestibular nuclei [7,8], suggesting the possibility that the
antivertigo effect of histamine-related drugs occurs cen-
trally. On the other hand, experiments performed on
amphibian semicircular canals have shown that H1 and
H3 receptor ligands affect the sensory input recorded from
the afferent vestibular neurons [9-11], indicating a possi-
ble peripheral site of action for these drugs. Consonant
with the latter studies, we recently reported that H1 recep-
tors are expressed in frog and mouse hair cells [12].
In the present study we report that a subpopulation of
mouse Scarpa's ganglion neurons innervating both Type I
and Type II hair cells express H3 receptors.
Methods
Experiments were performed on mice (Swiss CD-1) about
3 weeks old. All experimental procedures involving ani-
mals were approved by the Ministero Italiano della Sanità,
and comply with the European international laws on ani-
mal research. Prior to any surgery, deep and irreversible
anesthesia was obtained by means of alothane.
RT-PCR
For RT-PCR experiments, brain and vestibular ganglia
were removed immediately after decapitation of the ani-
mal. The superior and inferior vestibular ganglia were
removed together. Since both ganglia similarly stained for
the H3 receptor (H3R) antibody, no differential analysis
was performed.
Total RNA was extracted from mouse brain (1 mouse/
experiment for 3 experiments) and Scarpa's vestibular
ganglia (50–100 mice/experiment for 3 experiments)
using QIAzol Lysis Reagent (QUIAGEN, Italy). Single-
strand cDNA was synthesized from RNA (1 μg) using ran-
dom hexamers and M-MLV Reverse Transcriptase (Invitro-
gen, USA). Subsequently, PCR (30 s at 96°C, then 30 s at
62°C or 69°C for β-actin and H3 respectively, followed by
30 s at 72°C for 33 cycles) was performed on 2.5 μl cDNA
using specific primers for H3 receptors designed in
accordance with the published sequence. H3 receptors
display alternative splicing mainly in the region of the
third intracellular loop [13]. Primers for H3 receptors
were designed around a nonspliced region, so that all var-
iants would be detected, although not differentiated. The
forward and reverse sequences were: 5'-TTCAACATCGT-
GCTGATCAG-3' 5'-TGTTCAGGTAGATGCTGAGG-3. As
an internal control for cDNA yield, parallel RT-PCR was
performed using specific primers for mouse β-actin. The
primer sequences were: 5'-CAGATCATGTTTGAGACCTT-
3' 5'-CGGATGTCMACGTCACACTT-3'. Negative control
experiments were always performed by omitting the
reverse transcriptase. The molecular weight (MW) of PCR
products was estimated using the DNA MW marker VIII
(Roche Molecular Biochemicals, Italy).
Immunofluorescence
For immunofluorescence experiments ganglia were dis-
sected from mice (n = 8), embedded in Jung Tissue Freez-
ing Medium (Leica Microsystems, Italy) and immediately
frozen in liquid nitrogen. Multiple 10 μm cryostat sec-
tions were obtained from the frozen samples, washed
with phosphate-buffered saline (PBS) solution, blocked
for 60 min with bovine serum albumin (BSA) 3%, rinsed
with PBS and then incubated for 2 hours with rabbit anti-
rat H3R IgG (Alpha Diagnostic International, USA),
diluted 1:50 in PBS. After a rinse in PBS (15 min), the sec-
tions treated with anti-H3 were incubated (30 min) with
Alexa-fluor 488-conjugated anti-rabbit IgG (1:1000) (Inv-
itrogen, Italy).
No immunostaining was observed in control sections
incubated with H3R antibodies preadsorbed with 20 M
excess of the relative control peptide (Alpha Diagnostic
Reverse transcriptase-PCR analysis in the mouse vestibular  ganglia Figure 1
Reverse transcriptase-PCR analysis in the mouse ves-
tibular ganglia. A: mRNA RT-PCR for H3 receptor 
expression in mouse brain and Scarpa's ganglia. B: mRNA 
RT-PCR for β-actin expression in mouse brain and Scarpa's 
ganglia. The 307 and 509 bp bands correspond to the H3 and 
β-actin specific PCR products, respectively. β-actin mRNA 
was used as the internal control.BMC Neuroscience 2009, 10:70 http://www.biomedcentral.com/1471-2202/10/70
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International, USA), thus confirming anti-H3R antibody
specificity.
For the colocalization study of histamine receptors and
calretinin or calbindin, slices were incubated with rabbit
anti-rat H3R IgG (Alpha Diagnostic International, USA)
plus goat calretinin antiserum (Alpha Diagnostic Interna-
tional, USA), or plus goat calbindin antiserum (D28k-c20;
Santa Cruz Biotechnology Inc., Germany), all diluted 1:50
in PBS except for calretinin which was diluted 1:250. After
a rinse in PBS (15 min) the sections were incubated with
Alexa Fluor 488-conjugated anti-rabbit IgG (1:1000) and
Alexa Fluor 546-conjugated anti-goat IgG (1:1000). The
immunostained slices were examined using the AFTER®
fluorescence LED module (Fraen Corporation, Italy).
Nuclei were counterstained with DAPI (ProLong® Gold
antifade reagent with DAPI, Invitrogen, Italy). Slides were
mounted on an Olympus BX41 light microscope, and dig-
ital images were captured with an Olympus Camedia C-
5050 zoom digital camera (Olympus Italia, Italy). Several
images were also acquired by mean of a TCS SP2 LEICA
confocal microscopy system equipped with a LEICA DM
IRBE inverted microscope.
In two additional experiments ganglia were not dissected
directly from the mouse, but the petrous bone containing
the whole inner ear was dissected out surgically and post-
fixed in 4% paraformaldehyde in 0.1 M PB for 2–3 hr.
Bone was decalcified for at least 1 week in a 120 mM
EDTA solution at 4°C before further processing into par-
affin. Serial paraffin sections (10 μm) were brought to
water, washed with phosphate-buffered saline (PBS) solu-
tion, blocked for 60 min with BSA 3%, rinsed with PBS
and then incubated for 2 hr with anti-H3R antibody
(Alpha Diagnostic International, USA) diluted 1:50 in
PBS. After a rinse in PBS (15'), the slices were treated with
anti-H3R and incubated (30') with Alexa-fluor 488 anti-
rabbit IgG (Invitrogen, Milan, Italy). Slices were then
washed 3 × 5 min with PBS, mounted in ProLong® Gold
antifade reagent with DAPI (Molecular Probes) and exam-
ined with a TCS SP2 LEICA confocal microscopy system
equipped with a LEICA DM IRBE inverted microscope.
Neuron count and size
To estimate the percentage of ganglia neurons expressing
H3 receptors, we calculated the ratio of cells staining for
both H3 antibody and DAPI vs. cells staining for DAPI
only in ganglia slices. All nuclei that were clearly recogniz-
able were counted in slices. Since slices were 10 μm thick,
and neuron soma ranged between 10 and 30 μm, in serial
sections a same neuron could be counted twice. This
would have yielded to an overestimation of H3 expressing
neurons as they showed a larger soma (see Result sec-
tions). Therefore, we skipped one slice every count. The
same was done for calculating the percentage of cal-
retinin-positive neurons.
Finally, in some experiments ganglia tissue was stained
with toluidine blue or hematoxylin/eosin, which stain
neuron nuclei and cytoplasm. The diameter of each
nucleus and soma was obtained by averaging the largest
and the shortest diameters measured.
Analysis was performed with Microcal Origin (Version
6.0. Microcal Software, Northampton, MA, USA) and
Microsoft Excel V. 5 (Microsoft, Redmond, WA, USA).
Data are presented as means ± standard deviation; n =
number of cases.
Results
Expression of H3 histamine receptor mRNA in the mouse 
vestibular ganglia tissue
RT-PCR was performed to evaluate the expression of H3
receptor mRNA in mouse vestibular ganglia. Fig. 1A
Immunofluorescence of histamine H3 receptors in mouse Scarpa's ganglion Figure 2
Immunofluorescence of histamine H3 receptors in mouse Scarpa's ganglion. A: light microscope photomicrograph 
of a Scarpa's ganglion slice. H3 receptors appeared expressed in neurons characterized by large nuclei. White arrows point at 
three such neurons. B: confocal light photomicrograph of an enlarged image from a different ganglion slice. C: light microscope 
photomicrograph from a different ganglion slice, following H3R antibody preabsorption (see Methods). No labeling for H3R is 
detectable. Green: H3R antibody; Blue: DAPI. Slice thickness: 10 μm. Calibration bar: 20 μm.BMC Neuroscience 2009, 10:70 http://www.biomedcentral.com/1471-2202/10/70
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shows representative agarose gel electrophoresis results
for H3 mRNA expression in mouse vestibular ganglia and
brain. Bands for H3 mRNAs were obtained for both con-
trol tissue (brain) and ganglia. The good quality of the
mRNA extracted from the labyrinth was confirmed by the
presence of the β-actin band (Fig. 1B).
H3 protein receptor immunofluorescence
Immunofluorescence experiments were performed both
in slices obtained from ganglia dissected and fixed, and
following decalcification of the whole petrous bone (see
Methods). No obvious differences were found between
the two methods.
On average, 30% of all neurons in the slices (± 9%; n =
1264 – tissue from 8 ganglia) stained for the H3R anti-
body. This neuronal subpopulation was characterized by
a large and roundish nucleus and soma, and by an une-
venly dense distribution of chromatin in the nucleoplasm
(Fig. 2A and 2B). The specificity of the H3R antibody was
confirmed by preabsorption experiments with the anti-
body control peptide (Fig. 2C).
Large soma neurons in rodent vestibular ganglia were
reported to stain for calretinin and calbindin, two calcium
binding proteins, whereas small soma neurons stained for
peripherin [14,15]. We therefore investigated if H3R-pos-
itive neurons fitted in the calretinin/calbindin neuronal
subpopulations.
Co-labeling of H3 receptors and calretinin/calbindin
Fig. 3 shows that a subpopulation of H3R-positive neu-
rons additionally labels for calretinin, which is considered
a pure marker of vestibular calyx afferents [14,15]. The co-
localization with calretinin was observed in 21% (± 4.9%;
n = 1264 – tissue from 8 ganglia) of H3R positive neurons.
The large soma neurons labeling for H3R but not cal-
retinin should include dimorphic neurons innervating
both Type I and Type II hair cells. Calyx and dimorphic
neurons were reported to immunostain for calbindin
[14,15]. To confirm this assumption, in six slices from two
different ganglia we tested if H3 receptors co-localized
with calbindin. As shown in Fig. 4, practically all H3R-
positive neurons also stained for calbindin.
Size of H3-positive neurons
Antibodies for calretinin, calbindin and H3 receptors
apparently marked only neurons characterized by large
soma and nucleus. However, since DAPI only stains the
nucleus, it is not possible to exclude that some neurons
not expressing H3 receptors or calretinin/calbindin had a
small nucleus but a large soma. To test for this possibility
we measured the soma and nucleus of neurons counter-
stained with hematoxylin/eosin or toluidine blue, which
stain both nucleus and cytoplasm (see e.g. Fig. 5A). As
depicted in Fig. 5B, soma and nucleus diameter of neu-
rons covary (correlation coefficient: 0.85), suggesting that
neurons showing a small nucleus also have a small soma.
Furthermore, H3-positive cells appeared grouped in the
upper part of the graph distribution, corresponding to
neurons characterized by largest soma and nucleus. The
mean nucleus diameter was 16.4 μm (± 4.2; n = 382) for
H3 positive neurons and 16.9 μm (± 13.7; n = 223) for
calretinin-positive neurons respectively.
Immunofluorescence of calretinin and histamine H3 receptor  in mouse Scarpa's ganglion Figure 3
Immunofluorescence of calretinin and histamine H3 
receptor in mouse Scarpa's ganglion. A: confocal image 
of a Scarpa's ganglion slice immunolabeled for H3 receptors. 
B: Immunolabeling for calretinin, same field as in A. C: nuclei 
counterstained with DAPI, same field as in A and B. D: over-
lapped images; yellow indicates the colocalization of cal-
retinin and H3 receptors (three examples shown by arrows). 
Calibration bar: 10 μm. Cryostat slices thickness: 5 μm. 
Green: H3R Alexa Fluor 488; Red: Calretinin Alexa Fluor 
546; Blue: DAPI. a, b, c and d are larger magnifications from a 
different slice, same antibodies and description as above. Cal-
ibration bar: 20 μm.BMC Neuroscience 2009, 10:70 http://www.biomedcentral.com/1471-2202/10/70
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Discussion
Our RT-PCR experiments showed that mouse vestibular
ganglia express the mRNA for H3 histamine receptors.
Moreover, antibodies anti-H3R protein stained neurons
characterized by a relatively large soma and nucleus. This
is the first report of H3 receptors expression by primary
vestibular neurons, suggesting they could represent a
peripheral target of histamine-related drugs, besides hista-
mine receptors expressed by neurons of the vestibular
nuclei, which are a central target.
About one fifth (21%) of H3R-positive neurons expressed
calretinin, and virtually all co-labeled for calbindin. Cal-
retinin was reported to selectively mark pure vestibular calyx
afferents which innervate Type I hair cells only, while calbin-
din additionally labeled dimorphic afferents contacting both
Type I hair and Type II hair cells [14,15]. A third neuronal
subpopulation was also identified, characterized by the
smallest soma, which stained with peripherin; these neurons
make bouton-like synapses on Type II hair cells only.
Taken together, our results indicate that H3 receptors are
expressed by calyx and dimorphic, but not bouton, affer-
ent neurons.
Calyx, dimorphic and bouton afferents, beside innervat-
ing different proportions of Type I vs. Type II hair cells,
show distinct regional distributions in the sensory epithe-
lia [15,16] and diverse resting and dynamic discharge
properties [17]. The reason for this afferent diversity is not
fully understood, although it has been proposed that it
might serve to match different vestibular reflexes [17]. It
seems interesting here to note that the expression of H3
receptors represents an additional difference among pri-
mary vestibular afferent neurons.
Role of H3 receptors in vestibular ganglion neurons
H3 antagonists were shown to inhibit the afferent dis-
charge recorded from the vestibular nerve of the axolotl
[10,11]. It was proposed that H3 receptors were localized
post-synaptically to the hair cells, i.e. at the afferent vestib-
Scarpa's ganglion neurons size Figure 5
Scarpa's ganglion neurons size. A: Photomicrograph of a 
typical ganglion slice counterstained with ematoxylin/eosin, 
which stains both nucleus and cytoplasm. Calibration bar: 20 
μm. B: scatter plot showing neuronal soma and relative 
nucleus diameter in a typical slices stained with hematoxylin/
eosin (squares) and in a typical slice stained for the H3R anti-
body (filled squares). The equation for the regression line 
and the correlation coefficient value are shown in figure.
Immunofluorescence of calbindin and histamine H3 receptor  in mouse Scarpa's ganglion Figure 4
Immunofluorescence of calbindin and histamine H3 
receptor in mouse Scarpa's ganglion. All confocal 
images refer to the same field. A: slice immunolabeled for H3 
receptors. B: Immunolabeling for calbindin. Note that, 
although staining is less homogeneous than in A, there is a 
substantial overlap of the stained soma. C: nuclei counter-
stained with DAPI. D: overlapped images; yellow indicates 
the co-localization of calbindin and H3R. Calibration bar: 20 
μm. Cryostat slices thickness: 5 μm. Green: H3R Alexa Fluor 
488; Red: Calbindin Alexa Fluor 546; Blue: DAPI.Publish with BioMed Central    and   every 
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ular nerve, since H3 antagonists were still effective when
the synapse was blocked by a high Mg2+/low Ca2+ solution
[11]. This hypothesis is consistent with the present results,
and also with a recent study showing no evidence for H3
receptors expression by vestibular hair cells [12].
On the whole, these results suggests that histamine, and
related compounds, can affect the excitability of primary
vestibular neurons through direct action on H3 receptors.
This conclusion, however, does not exclude a possible
pre-synaptic effect of H3 receptors upon glutamatergic
neurotransmission between Scarpa's ganglion neurons
and second order neurons located in the vestibular nuclei
and in the vestibolocerebellum. Although in fact H3
receptors are commonly found on histaminergic nerve
endings where, by acting as autoreceptors, they are
responsible for histamine inhibiting its own release, they
have also been found on nonhistaminergic endings
whereby histamine can inhibit release of different neuro-
transmitters, among which glutamate [18].
Conclusion
The main original finding of the present study is that
mouse vestibular ganglion neurons express histamine H3
receptors. Interestingly, data are consistent with H3 recep-
tors being expressed by calyx and dimorphic, but not bou-
ton, afferents. This suggests the possibility that histamine
modulates distinct sensory pathways. Finally, it is possible
to speculate that the anti-vertigo action reported for some
histamine-related drugs involves H3 receptors expressed
by primary vestibular neurons.
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